Web3 months. This cookie is used by Google Analytics to understand user interaction with the website. _gid. 1 day. This cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. WebPrognostic value of deep learning based mitotic count in hormonal receptor- and HER2-positive breast cancer
Dynamics of Long-Term Patient-Reported Quality of Life and …
WebApr 22, 2024 · Barbara Pistilli reports consulting/advising for Puma Biotechnology, Novartis, Myriad Genetics, and Pierre Fabre; meeting and/or travel support from Novartis, AstraZeneca, MSD Oncology, and Pfizer; and research funding from Daiichi, Puma … WebApr 1, 2024 · @article{Pistilli2024PhaseIS, title={Phase II study of buparlisib (BKM120) and trastuzumab in patients with HER2+ locally advanced or metastatic breast cancer resistant to trastuzumab-based therapy}, author={Barbara Pistilli and Tj Pluard and Ander Urruticoechea and Daniele Farci and Anthony Kong and Thomas Bachelot and Steve … hnsdiag
Department Medical Oncology Senior Staff Gustave Roussy
WebView the profiles of professionals named "Barbara Pistilli" on LinkedIn. There are 3 professionals named "Barbara Pistilli", who use LinkedIn to exchange information, ideas, and opportunities. WebMar 7, 2024 · Newer, combined, and longer therapies will hopefully improve the outcomes for high-risk disease," Barbara Pistilli, MD, of Gustave Roussy Cancer Center in Villejuif, France, and colleagues wrote ... WebOct 19, 2024 · 1 Breast Cancer Group, GUSTAVE ROUSSY, 94800 - Villejuif/FR; 2 Pharmacologist Unit And Sipam, GUSTAVE ROUSSY, 94800 - Villejuif/FR; 3 Team Oncostat, Cesp, Gustave Roussy, 94805 - Villejuif/FR; 4 Medical Oncology, University of Lisbon, lisbon/PT; 5 Medical Oncology, Institut Curie, 75248 cedex5 - Paris/FR; 6 … hnsc database